Collaboration will fund research to develop new drugs to treat gastrointestinal disorders
02.9.22
Read More
Activating CGRP receptors generates pain signals within Schwann cells, but blocking CGRP actions inside Schwann cells offers potential new treatments for migraine pain
02.3.22
NYU, Columbia, and Takeda Form Research Alliance for Gastrointestinal and Liver Disorders
11.23.2020
Past PARC Events: Endosomal Platforms for the Signaling Train to Pain
10.28.2020
Funding Comes Through NIH’s HEAL Initiative to Stem Opioid Crisis
09.25.2020
Scientists Use Nanoparticles to Target Drug to Receptors, Offering Sustained Relief for Chronic Pain in Cellular Study of Inflammatory Bowel Disease
06.15.2020
Studies of Pain Drug Delivery and Maternal Health Chosen for Bracket Competition of Innovative Research in Biomedical Science
02.24.2020
An #NIH-funded study @nyuniversity used nanoparticles to deliver a non-opoid drug directly into specific compartments in nerve cells ...
11.08.2019
Research uses nanoparticles to infuse a non-opioid drug into nerves to provide enhanced pain relief.
11.04.2019
$2.7 million grant funds collaboration to understand the role of protease-activated receptor 2 in chronic pain associated with irritable bowel syndrome and inflammatory bowel disease.
10.16.2019
